Samsung’s Heir Apparent Bets Big on Biotechnology Business
Samsung broke ground on a new drug manufacturing plant Monday, vowing to take a share of the growing biopharmaceutical industry by outshining rivals with speed and cost-efficiency.
Baca Berita Asal
Bagikan Berita Ini
Subscribe to:
Post Comments (Atom)
0 Response to "Samsung’s Heir Apparent Bets Big on Biotechnology Business"
Post a Comment